Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer.

<h4>Objective</h4>Better biomarkers are needed in order to identify patients with endometrial carcinoma at risk of recurrence and who may profit from a more aggressive treatment regimen. Our objective was to explore the applicability of plasma growth differentiation factor 15 (GDF-15) as a marker fo...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Hilde Engerud, Kirsten Hope, Hege Fredriksen Berg, Kristine Eldevik Fasmer, Ingvild Løberg Tangen, Ingfrid Salvesen Haldorsen, Jone Trovik, Camilla Krakstad
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Public Library of Science (PLoS) 2019-01-01
Σειρά:	PLoS ONE
Διαθέσιμο Online:	https://doi.org/10.1371/journal.pone.0210585
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!